Osteoarthritis is a degenerative condition impacting more than 30 million adults in the US. This collaboration will focus on the promotion of Zilretta (triamcinolone acetonide extended-release injectable suspension), The post Johnson & Johnson, Pacira partner to expand osteoarthritis treatment options appeared first on Pharmaceutical Business review.
